Adenosine 2A Receptor Antagonist Prevented and Reversed Liver Fibrosis in a Mouse Model of Ethanol-Exacerbated Liver Fibrosis

• Dian J. Chiang,

  Affiliation Center for Liver Disease Research, Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Sanjoy Roychowdhury,

  Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Katelyn Bush,

  Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Megan R. McMullen,

  Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Sorana Pisano,

  Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Kathryn Niese,

  Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Mitchell A. Olman,

  Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Michele T. Pritchard,

  Current address: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America

  ⨯
• Laura E. Nagy

  * E-mail: nagyL3@ccf.org

  Affiliations Center for Liver Disease Research, Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America, Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, United States of America

  ⨯